Is a complete CSE/OMND research report available?

No complete published report is available for cse/OMND (CSE/OMND) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

cse/OMND stock profile | StockMarketAgent.AI

Accedi Start free

CSE/OMND (CSE/OMND)

Canadian Securities Exchange: CSE/OMND · CAD

CA$0.01

+0.00 (0.0%)· Recorded snapshot

Market cap	515.7K
Revenue (ttm)	121.3K
Net income (ttm)	-117.9K
EPS (ttm)	-CA$0.00
Shares out	103.1M
Volume	50,000
Beta	0.13

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 121.3K
Net income (ttm): -117.9K
EPS (ttm): -CA$0.00
Market cap: 515.7K

All CSE/OMND indicators

Market & fundamental data

Available fields

128

Groups with data

Currency

CAD

Showing 128 of 128 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-03
Enterprise value	CAD 530,092
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-02-28
First seen	2026-05-10
Fiscal year end	February
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA68405U1012
Last earnings date	2026-01-29
Last refreshed	2026-10-29
Market cap	CAD 515,742
Next earnings date	2026-11-03
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
SIC code	8000
Stock price date	2025-09-11
Symbol	cse/OMND
Website	https://optimindpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-22.78%
EV/Sales	4.37x
Industry forward P/E	34.4x
P/(OCF - SBC) ratio	34.86x
P/OCF ratio	33.07x
P/S ratio	4.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-35.27%
Gross margin	62.33%
Operating margin	-35.27%
Pretax margin	-97.23%
Profit margin	-97.23%
ROA	-15.61%
ROCE	22.88%
SBC / revenue	0.66%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	3
Gross profit growth	9.61%
Gross profit growth (Q)	-7.99%
Gross profit growth 3Y	13.38%
Net income growth years	3
Revenue growth	2.47%
Revenue growth (Q)	-29.36%
Revenue growth (QoQ)	-27.96%
Revenue growth 3Y	-10.66%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	CAD -42,782
EPS	CAD -0.00
Gross profit	CAD 75,602
Net cash flow	CAD 15,595
Net income	CAD -117,935
Operating cash flow minus SBC	CAD 14,795
Operating income	CAD -42,782
Revenue	CAD 121,293
Stock-based compensation	CAD 800

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-51
Book value per share	CAD -0.00
Long-term assets	CAD 0
Long-term liabilities	CAD 0
Net cash (debt)	CAD -21,268
Net cash / market cap	-4.12%
Piotroski F-Score	4
Shareholders' equity	CAD -186,964
Tangible book value	CAD -186,964
Tangible book value per share	CAD -0.00
Total assets	CAD 142,551
Total cash	CAD 99,369
Total debt	CAD 120,637
Total liabilities	CAD 329,515
WACC	4.02%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.71
Current assets	CAD 142,551
Current liabilities	CAD 329,515
Current ratio	0.43
Net working capital	CAD -165,696
Quick ratio	0.43
Working capital	CAD -186,964
Working capital turnover	-0.78

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	7.14%
Shareholder yield	7.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.01
1D price change	0%
20-day SMA	CAD 0.01
3M price change	-50%
3M total return	-50%
3Y price change	-91.67%
3Y return CAGR	-56.31%
3Y total return	-91.67%
50-day SMA	CAD 0.01
52-week high	CAD 0.01
52-week high date	2025-07-25
52-week low	CAD 0.01
52-week low date	2025-09-11
All-time high	CAD 0.20
All-time high date	2022-08-04
All-time low	CAD 0.01
All-time low date	2023-11-29
Average true range (ATR)	CAD 0.00
Average volume	32.5K
Beta (1Y)	0
Beta (2Y)	-1.82
Beta (5Y)	0.13
Change from 52-week high	-50%
Change from 52-week low	0%
Change from all-time high	-97.5%
Change from all-time low	0%
Change from open	0%
Day's gap	0%
Dollar volume	CAD 250
High price	CAD 0.01
Low price	CAD 0.01
Monthly RSI	37.94
Open price	CAD 0.01
Previous close	CAD 0.01
Price vs 150-day SMA	-63.77%
Price vs 20-day SMA	-33.33%
Price vs 50-day SMA	-19.35%
Relative volume	1.54
RSI	40.4
Sharpe ratio	0.6
Sortino ratio	1.04
Volume	50K
Weekly RSI	28.55

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	0.01%
Shares change (YoY)	-7.14%
Shares outstanding	103.1M

CSE/OMND (CSE/OMND)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/OMND

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/OMND indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/OMND

Frequently asked questions